conivaptan: Clinical Trials

4 trials of conivaptan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated, 1 withdrawn. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 2, Terminated 1, Withdrawn 1

Follow conivaptan: new trials by email Literature Review of conivaptan trials Research Report on conivaptan

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects on Exercise Hemodynamics of Vasopressin Blockade by Conivaptan Infusion in Heart Failure Patients
Conivaptan, Placebo (Dextrose) - Heart Failure
Phase 4CompletedFinn Gustafsson202013-12-012015-06-17
Diuretic and Renal Effects of Vaprisol When Administered Along With Furosemide and Nesiritide Continuous Infusion
Conivaptan, Placebo - Heart Failure
Phase 4WithdrawnAlbert Einstein Healthcare Network2008-10-012011-06-23
Use of Conivaptan (Vaprisol) for Hyponatremic Neuro-ICU Patients
Conivaptan - Hyponatremia
Phase 4TerminatedNorthwestern University62008-08-012022-03-28
A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia
Conivaptan, placebo - Hyponatremia, Euvolemia
Phase 4CompletedCumberland Pharmaceuticals1212007-01-012014-05-15

Conditions studied

Heart Failure (2)  ·  Hyponatremia (2)  ·  Diabetes Insipidus (1)  ·  Edema (1)

Sponsors

Albert Einstein Healthcare Network (1)  ·  Cumberland Pharmaceuticals (1)  ·  Finn Gustafsson (1)  ·  Northwestern University (1)

Countries

Denmark (1)  ·  India (1)  ·  Israel (1)  ·  United States (1)

Top investigators

Andrew M Naidech, MD, MSPH (1)  ·  Art Wheeler, MD (1)  ·  Darshak H Karia, MD (1)  ·  Finn Gustafsson, MD, PhD, DMSci (1)  ·  Louise Balling, MD (1)

Results publications

PMID 20568023, PMID 30057012